ES2143487T3 - 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales. - Google Patents

1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.

Info

Publication number
ES2143487T3
ES2143487T3 ES93201058T ES93201058T ES2143487T3 ES 2143487 T3 ES2143487 T3 ES 2143487T3 ES 93201058 T ES93201058 T ES 93201058T ES 93201058 T ES93201058 T ES 93201058T ES 2143487 T3 ES2143487 T3 ES 2143487T3
Authority
ES
Spain
Prior art keywords
antiviral agents
alcoxy
alkylene
atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93201058T
Other languages
English (en)
Spanish (es)
Inventor
Guy Dominic Diana
Theodore John Nitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2143487T3 publication Critical patent/ES2143487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES93201058T 1992-04-15 1993-04-13 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales. Expired - Lifetime ES2143487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/869,287 US5349068A (en) 1992-04-15 1992-04-15 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents

Publications (1)

Publication Number Publication Date
ES2143487T3 true ES2143487T3 (es) 2000-05-16

Family

ID=25353269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93201058T Expired - Lifetime ES2143487T3 (es) 1992-04-15 1993-04-13 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.

Country Status (26)

Country Link
US (3) US5349068A (enEXAMPLES)
EP (1) EP0566199B1 (enEXAMPLES)
JP (1) JP3103845B2 (enEXAMPLES)
KR (1) KR100314158B1 (enEXAMPLES)
AT (1) ATE189958T1 (enEXAMPLES)
AU (1) AU666528B2 (enEXAMPLES)
CA (1) CA2094012C (enEXAMPLES)
CZ (1) CZ285845B6 (enEXAMPLES)
DE (1) DE69327913T2 (enEXAMPLES)
DK (1) DK0566199T3 (enEXAMPLES)
ES (1) ES2143487T3 (enEXAMPLES)
FI (1) FI112229B (enEXAMPLES)
GR (1) GR3033486T3 (enEXAMPLES)
HU (2) HU220606B1 (enEXAMPLES)
IL (1) IL105372A (enEXAMPLES)
MX (1) MX9302169A (enEXAMPLES)
MY (1) MY110191A (enEXAMPLES)
NO (1) NO302700B1 (enEXAMPLES)
NZ (1) NZ247411A (enEXAMPLES)
PH (1) PH30454A (enEXAMPLES)
PT (1) PT566199E (enEXAMPLES)
RU (1) RU2114112C1 (enEXAMPLES)
SG (1) SG50663A1 (enEXAMPLES)
SK (1) SK279786B6 (enEXAMPLES)
TW (1) TW239140B (enEXAMPLES)
UA (1) UA35557C2 (enEXAMPLES)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5552420A (en) * 1994-05-13 1996-09-03 Sterling Winthrop Inc. Therapeutic phenoxyalkylazoles and phenoxyalkylazines
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6348324B1 (en) 1999-01-21 2002-02-19 Hypoguard America Limited Composition and device for detecting leukocytes in urine
US6528652B1 (en) 1999-01-21 2003-03-04 Chronimed Composition and device for detecting leukocytes in urine
AUPQ105499A0 (en) 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
IL159086A0 (en) * 2001-06-08 2004-05-12 Cytovia Inc 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
US7129359B2 (en) * 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
US20050027127A1 (en) * 2001-08-29 2005-02-03 Diana Guy D. Oxadiazolyl-phenoxyalkylisoxazoles compositions thereof and methods for their use as anti-picornaviral agents
CA2459376A1 (en) * 2001-08-29 2003-03-13 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
US7652050B2 (en) * 2001-12-07 2010-01-26 Laboratorio de Siagnóstico GAM S.A Methods for increasing the survival of aquatic animals infected with an aquatic virus
AU2003215246A1 (en) * 2002-02-14 2003-09-04 Viropharma Incorporated Methods of reducing rhinovirus contagion and related compositions
EP1581213A4 (en) * 2002-12-18 2008-11-19 Cytovia Inc 3,5-DISUBSTITUTED 1,2,4-OXADIAZOLE AND ANALOGUE TO ACTIVATE CASPASE AND INTRODUCTION OF APOPTOSIS AND THEIR USE
US7259174B2 (en) * 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
US20060030550A1 (en) * 2004-08-04 2006-02-09 Lithgow Theodore L Pharmaceutical formulations
US20070202055A1 (en) * 2006-02-09 2007-08-30 Julianne Berry Pharmaceutical Formulations
EP1981476A2 (en) * 2006-02-09 2008-10-22 Schering Corporation Pharmaceutical formulations
EP1981545A2 (en) * 2006-02-09 2008-10-22 Schering Corporation Pharmaceutical formulations
WO2008071587A2 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
KR101031584B1 (ko) * 2009-04-21 2011-04-27 파인오토시스템(주) 전면부가 개폐되는 차량용 적외선 조사장치
CN103102348B (zh) * 2011-11-14 2016-06-08 上海交通大学 噁二唑类化合物及其制备方法、药物组合物及其用途
CA3104054A1 (en) 2018-08-21 2020-02-27 Kyorin Pharmaceutical Co., Ltd. Bicyclic heteroaromatic ring derivative
CA3152534A1 (en) * 2019-09-27 2021-04-01 Collaborations Pharmaceuticals, Inc. Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846525B (en) * 1983-08-29 1985-04-24 Sterling Drug Inc (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
CA1299176C (en) * 1985-07-02 1992-04-21 Guy Dominic Diana Process for preparing isoxazole and furan derivatives
US4843087A (en) * 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
US4861791A (en) * 1983-08-29 1989-08-29 Sterling Drug Inc. Dihydro-oxazolyl substituted-phenyl-aliphatic lower alkyl and their use as antiviral agents
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US5175178A (en) * 1989-08-21 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US4945164A (en) * 1989-08-18 1990-07-31 Sterling Drug Inc. 1,3,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents and intermediates thereof
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
US4942241A (en) * 1989-08-21 1990-07-17 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5175177A (en) * 1991-07-17 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents

Also Published As

Publication number Publication date
ATE189958T1 (de) 2000-03-15
FI112229B (fi) 2003-11-14
SG50663A1 (en) 1998-07-20
DE69327913T2 (de) 2000-10-12
NO931366D0 (no) 1993-04-14
KR930021637A (ko) 1993-11-22
DE69327913D1 (de) 2000-04-06
TW239140B (enEXAMPLES) 1995-01-21
MY110191A (en) 1998-02-28
US5643929A (en) 1997-07-01
PH30454A (en) 1997-05-28
JPH0649066A (ja) 1994-02-22
HU220606B1 (hu) 2002-03-28
NZ247411A (en) 1994-06-27
SK279786B6 (sk) 1999-03-12
EP0566199B1 (en) 2000-03-01
HU9301084D0 (en) 1993-06-28
CZ59793A3 (en) 1994-02-16
CA2094012A1 (en) 1993-10-16
NO302700B1 (no) 1998-04-14
PT566199E (pt) 2000-09-29
AU3688193A (en) 1993-10-21
US5464848A (en) 1995-11-07
EP0566199A1 (en) 1993-10-20
CA2094012C (en) 2001-08-21
AU666528B2 (en) 1996-02-15
DK0566199T3 (da) 2000-06-19
SK35393A3 (en) 1994-06-08
GR3033486T3 (en) 2000-09-29
CZ285845B6 (cs) 1999-11-17
FI931707A0 (fi) 1993-04-15
KR100314158B1 (ko) 2002-02-19
HU211320A9 (en) 1995-11-28
NO931366L (no) 1993-10-18
IL105372A0 (en) 1993-08-18
US5349068A (en) 1994-09-20
RU2114112C1 (ru) 1998-06-27
UA35557C2 (uk) 2001-04-16
FI931707L (fi) 1993-10-16
HUT65574A (en) 1994-07-28
IL105372A (en) 1998-12-27
MX9302169A (es) 1993-10-01
JP3103845B2 (ja) 2000-10-30

Similar Documents

Publication Publication Date Title
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR0141913B1 (en) Anti-virus agents
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2123873T3 (es) Pirrolocarbazol.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
ES2189941T3 (es) Derivados de nucleosidos aciclicos.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
DK624989D0 (da) Hidtil ukendte forbindelser
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
ES2059550T3 (es) Derivados de la bencimidazola, su preparacion y su aplicacion en terapeutica.
DE3666223D1 (en) Anticonvulsant agents
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
ES2138052T3 (es) Derivados de ciclopropano y agentes antiviricos que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 566199

Country of ref document: ES